149 related articles for article (PubMed ID: 28223245)
1. Potential of single cationic amino acid molecule "Arginine" for stimulating oral absorption of insulin.
Kamei N; Khafagy ES; Hirose J; Takeda-Morishita M
Int J Pharm; 2017 Apr; 521(1-2):176-183. PubMed ID: 28223245
[TBL] [Abstract][Full Text] [Related]
2. A novel approach using functional peptides for efficient intestinal absorption of insulin.
Morishita M; Kamei N; Ehara J; Isowa K; Takayama K
J Control Release; 2007 Apr; 118(2):177-84. PubMed ID: 17270307
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of cell-penetrating peptides to improve intestinal insulin absorption.
Kamei N; Morishita M; Eda Y; Ida N; Nishio R; Takayama K
J Control Release; 2008 Nov; 132(1):21-5. PubMed ID: 18727945
[TBL] [Abstract][Full Text] [Related]
4. Oligoarginine-modified biodegradable nanoparticles improve the intestinal absorption of insulin.
Liu X; Liu C; Zhang W; Xie C; Wei G; Lu W
Int J Pharm; 2013 May; 448(1):159-67. PubMed ID: 23538098
[TBL] [Abstract][Full Text] [Related]
5. Effects of intestinal luminal contents and the importance of microfold cells on the ability of cell-penetrating peptides to enhance epithelial permeation of insulin.
Kamei N; Kawano S; Abe R; Hirano S; Ogino H; Tamiwa H; Takeda-Morishita M
Eur J Pharm Biopharm; 2020 Oct; 155():77-87. PubMed ID: 32781024
[TBL] [Abstract][Full Text] [Related]
6. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
[TBL] [Abstract][Full Text] [Related]
7. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.
Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M
AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471
[TBL] [Abstract][Full Text] [Related]
8. Determination of the optimal cell-penetrating peptide sequence for intestinal insulin delivery based on molecular orbital analysis with self-organizing maps.
Kamei N; Kikuchi S; Takeda-Morishita M; Terasawa Y; Yasuda A; Yamamoto S; Ida N; Nishio R; Takayama K
J Pharm Sci; 2013 Feb; 102(2):469-79. PubMed ID: 23160942
[TBL] [Abstract][Full Text] [Related]
9. Enhanced Oral Delivery of Bisphosphonate by Novel Absorption Enhancers: Improvement of Intestinal Absorption of Alendronate by N-Acyl Amino Acids and N-Acyl Taurates and Their Absorption-Enhancing Mechanisms.
Nakaya Y; Takaya M; Hinatsu Y; Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
J Pharm Sci; 2016 Dec; 105(12):3680-3690. PubMed ID: 27771051
[TBL] [Abstract][Full Text] [Related]
10. Efficacy, safety and mechanism of HP-β-CD-PEI polymers as absorption enhancers on the intestinal absorption of poorly absorbable drugs in rats.
Zhang H; Huang X; Zhang Y; Gao Y
Drug Dev Ind Pharm; 2017 Mar; 43(3):474-482. PubMed ID: 27892724
[TBL] [Abstract][Full Text] [Related]
11. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
[TBL] [Abstract][Full Text] [Related]
12. Hydrophobic Amino Acid Tryptophan Shows Promise as a Potential Absorption Enhancer for Oral Delivery of Biopharmaceuticals.
Kamei N; Tamiwa H; Miyata M; Haruna Y; Matsumura K; Ogino H; Hirano S; Higashiyama K; Takeda-Morishita M
Pharmaceutics; 2018 Oct; 10(4):. PubMed ID: 30308982
[TBL] [Abstract][Full Text] [Related]
13. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
[TBL] [Abstract][Full Text] [Related]
14. Permeation characteristics of oligoarginine through intestinal epithelium and its usefulness for intestinal peptide drug delivery.
Kamei N; Morishita M; Ehara J; Takayama K
J Control Release; 2008 Oct; 131(2):94-9. PubMed ID: 18692532
[TBL] [Abstract][Full Text] [Related]
15. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
16. Insulin-cell penetrating peptide hybrids with improved intestinal absorption efficiency.
Liang JF; Yang VC
Biochem Biophys Res Commun; 2005 Sep; 335(3):734-8. PubMed ID: 16115469
[TBL] [Abstract][Full Text] [Related]
17. [Development of an oligoarginine peptide displaying rapid cell penetration for improved intestinal absorption].
Takayama K
Yakugaku Zasshi; 2014; 134(1):55-61. PubMed ID: 24389618
[TBL] [Abstract][Full Text] [Related]
18. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
19. Mucosal insulin delivery systems based on complexation polymer hydrogels: effect of particle size on insulin enteral absorption.
Morishita M; Goto T; Peppas NA; Joseph JI; Torjman MC; Munsick C; Nakamura K; Yamagata T; Takayama K; Lowman AM
J Control Release; 2004 May; 97(1):115-24. PubMed ID: 15147809
[TBL] [Abstract][Full Text] [Related]
20. Oral absorption enhancement of salmon calcitonin by using both N-trimethyl chitosan chloride and oligoarginines-modified liposomes as the carriers.
Huang A; Su Z; Li S; Sun M; Xiao Y; Ping Q; Deng Y
Drug Deliv; 2014 Aug; 21(5):388-96. PubMed ID: 24188463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
